Trial intelligence / Profile preview

The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery

NCT04597372Phase 2Recruiting

Sponsor
Allegheny Singer Research Institute
Start
Nov 2021
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by Allegheny Singer Research Institute. Started Nov 2021; status: recruiting.

02

Drugs

tamsulosin
03

Conditions

postoperative urinary retention (POUR)

Beyond the preview

Go deeper on NCT04597372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04597372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call